Daiichi Sankyo Company (4568) Price & Analysis

Compare

14 Followers

4568 Stock Chart & Stats

Day’s Range― - ―

52-Week Range¥3,036.00 - ¥5,833.00

Previous CloseN/A

Volume4.34M

Average Volume (3M)5.31M

Market Cap

¥6.74T

Enterprise Value¥5.88T

Total Cash (Recent Filing)¥639.84B

Total Debt (Recent Filing)¥101.33B

Price to Earnings (P/E)22.5

Beta0.79

Next Earnings

Oct 29, 2025

EPS Estimate

40.76

Next Dividend Ex-Date

Sep 29, 2025

Dividend Yield1.66%

Share Statistics

EPS (TTM)46.03

Shares Outstanding1,894,350,600

10 Day Avg. Volume4,355,990

30 Day Avg. Volume5,308,743

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

¥5,800.41

Price Target Upside60.19% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

Bulls Say, Bears Say

Bulls Say

Corporate ConfidenceA recent JPY200Bn-buyback was conducted in defiance of the weak stock price, indicating confidence in the company's corporate value.

Drug DevelopmentAdvancing to Enhertu’s filing for 1L HER2+ BC with strong DB09 interim data shows promising progress in drug development.

FDA ApprovalFDA has approved anticancer candidate Dato-DXd for breast cancer, which is considered a positive surprise by the market.

Bears Say

Disappointing Study DataDaiichi's shares have declined by about 1/3 since the company reported disappointing Ph2 data from the TROPION-Lung01 study.

Stock DeclineDaiichi's shares have declined by about 1/3 since the company reported disappointing data from a lung cancer study.

Daiichi Sankyo Company News

AstraZeneca’s Ongoing Study on New Breast Cancer Treatment Shows Promise

AstraZeneca (($AZN)), AstraZeneca plc (($GB:AZN)), AstraZeneca (($DE:ZEGA)), Daiichi Sankyo Company (($DSKYF)), AstraZeneca plc US (($AZNCF)) announced an update...

1M ago

AZN

Daiichi Sankyo’s Promising Future: Buy Rating Backed by ADC Advancements and Strategic Growth Initiatives

Bernstein analyst Miki Sogi has maintained their bullish stance on DSKYF stock, giving a Buy rating on April...

4M ago

Daiichi Sankyo Reports Strong Fiscal Year Growth

Daiichi Sankyo Company ( ($DSKYF) ) has released its Q4 earnings. Here is a breakdown of the information...

4M ago

Daiichi Sankyo Reports Robust Q3 Earnings Performance

Daiichi Sankyo Company (($JP:4568)) has held its Q3 earnings call. Read on for the main highlights of the...

7M ago

DSKYF Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Daiichi Sankyo Company (DSKYF) is scheduled to report 3rd quarter earnings on 01/31/2025. Regarding Q3 estimates, Wall Street...

7M ago

Merck (NYSE:MRK) Slides after “Guided Missile” Cancer Drug Is Declined

It was bad news for Merck (NYSE:MRK) today as the drug maker found itself with a dud for...

1y ago

MRK

Merck (NYSE:MRK) Joins Hands with Daiichi Sankyo to Develop Cancer Drugs

American multinational pharmaceutical company Merck (NYSE:MRK) is joining hands with Japanese drug maker Daiichi Sankyo (OTCMKTS:DSKYF) to develop...

2y ago

MRK

Esperion Tanks after Dispute with Daiichi Sankyo

Esperion Therapeutics (NASDAQ: ESPR) cratered by more than 50% in pre-market trading on Thursday after the pharmaceutical company stated...

2y ago

ESPR

4568 FAQ

What was Daiichi Sankyo Company ’s price range in the past 12 months?

Daiichi Sankyo Company lowest stock price was ¥3036.00 and its highest was ¥5833.00 in the past 12 months.

What is Daiichi Sankyo Company ’s market cap?

Daiichi Sankyo Company ’s market cap is ¥6.74T.

When is Daiichi Sankyo Company ’s upcoming earnings report date?

Daiichi Sankyo Company ’s upcoming earnings report date is Oct 29, 2025 which is in 53 days.

How were Daiichi Sankyo Company ’s earnings last quarter?

Daiichi Sankyo Company released its earnings results on Jul 31, 2025. The company reported ¥46.03 earnings per share for the quarter, beating the consensus estimate of ¥34.212 by ¥11.818.

Is Daiichi Sankyo Company overvalued?

According to Wall Street analysts Daiichi Sankyo Company ’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Daiichi Sankyo Company pay dividends?

Daiichi Sankyo Company pays a Semiannually dividend of ¥39 which represents an annual dividend yield of 1.66%. See more information on Daiichi Sankyo Company dividends here

What is Daiichi Sankyo Company ’s EPS estimate?

Daiichi Sankyo Company ’s EPS estimate is 40.76.

How many shares outstanding does Daiichi Sankyo Company have?

Daiichi Sankyo Company has 1,894,350,600 shares outstanding.

What happened to Daiichi Sankyo Company ’s price movement after its last earnings report?

Daiichi Sankyo Company reported an EPS of ¥46.03 in its last earnings report, beating expectations of ¥34.212. Following the earnings report the stock price went up 1.834%.

Which hedge fund is a major shareholder of Daiichi Sankyo Company ?

Currently, no hedge funds are holding shares in JP:4568

Company Description

Daiichi Sankyo Company

Daiichi Sankyo Company (4568) is a global pharmaceutical company based in Tokyo, Japan. It operates primarily in the fields of research, development, manufacturing, and commercialization of pharmaceutical products. The company's core focus areas include oncology, cardiovascular diseases, and rare diseases, with a strong emphasis on developing innovative therapies and solutions to address unmet medical needs. Daiichi Sankyo is renowned for its robust pipeline of drug candidates and its commitment to advancing healthcare through cutting-edge science and technology.

Daiichi Sankyo Company (4568) Earnings & Revenues

Historic Earnings Reports

4568 Company Deck

4568 Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

The earnings call presented a robust financial performance with significant revenue and profit growth, driven by strong product sales and successful patent settlements. However, slight downward adjustments in sales forecasts and potential financial uncertainties were noted.View all JP:4568 earnings summaries

4568 Stock 12 Month Forecast

Average Price Target

¥5,800.41

▲(60.19% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3318":"¥3,318","4629":"¥4,629","5940":"¥5,940","3973.5":"¥3,973.5","5284.5":"¥5,284.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5900.6485850114,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥5.90K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5800.412735953,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥5.80K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5700.1768868946,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥5.70K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3318,3973.5,4629,5284.5,5940],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3678,3848.9729680778,4019.9459361556,4190.9189042334,4361.8918723112,4532.864840389,4703.8378084668,4874.8107765446,5045.7837446224,5216.7567127002,5387.729680778,5558.7026488558,5729.6756169336,{"y":5900.6485850114,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3678,3841.262518150231,4004.5250363004616,4167.787554450692,4331.050072600923,4494.312590751154,4657.575108901385,4820.8376270516155,4984.100145201846,5147.362663352077,5310.625181502308,5473.887699652539,5637.1502178027695,{"y":5800.412735953,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3678,3833.5520682226615,3989.104136445323,4144.656204667985,4300.208272890646,4455.760341113308,4611.312409335969,4766.864477558631,4922.416545781292,5077.968614003954,5233.5206822266155,5389.072750449277,5544.624818671939,{"y":5700.1768868946,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5350.419,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5718.156,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5939.98,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4677.148,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4829.912,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4831.896,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4317.063,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3419.328,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3723,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3655,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3816,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3319,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3678,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >